MedTrace Logo

Medication Strategies for Treating Aggressive Behavior in Youth With Attention Deficit Hyperactivity Disorder

NCT00228046 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2013-10-31

No results posted yet for this study

Summary

This study will assess whether adding a mood stabilizer, divalproex sodium, to stimulant treatment is more effective than stimulant treatment alone in reducing aggressive behavior among children with attention deficit hyperactivity disorder (ADHD).

Conditions

  • Attention Deficit Disorder With Hyperactivity
  • Conduct Disorder
  • Oppositional Defiant Disorder

Interventions

DRUG

Divalproex Sodium

DRUG

Methylphenidate

DRUG

Dextroamphetamine

DRUG

Mixed Amphetamine Salts

BEHAVIORAL

Family Counseling

BEHAVIORAL

Behavior Management Training with Parents

Sponsors & Collaborators

Principal Investigators

  • Joseph C. Blader, PhD, MSc · Stony Brook State University of New York School of Medicine

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
6 Years
Max Age
14 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2004-01-31
Primary Completion
2007-07-31
Completion
2007-07-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00228046 on ClinicalTrials.gov